NCF2 Gene Granulomatous Disease Chronic Autosomal Recessive Cytochrome B-Positive Type 2 Genetic Test sale cost 4400 AED
RPS19 Gene Diamond-Blackfan Anemia Type 1 Genetic Test sale cost 4400 AED RPS19 Gene Diamond-Blackfan Anemia Type 1 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
CBLIF Gene Intrinsic Factor Deficiency Genetic Test sale cost 4400 AED CBLIF Gene Intrinsic Factor Deficiency Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

NCF2 Gene Granulomatous Disease Chronic Autosomal Recessive Cytochrome B-Positive Type 2 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The NCF2 gene is implicated in a rare genetic disorder known as Chronic Granulomatous Disease (CGD), specifically the autosomal recessive cytochrome b-positive type 2. CGD is characterized by the body’s inability to effectively combat infections, leading to the formation of granulomas, which are clusters of immune cells formed at sites of infection or inflammation. The NCF2 gene plays a critical role in the immune system’s functioning, particularly in the production of reactive oxygen species by phagocytes that are essential for killing certain bacteria and fungi.

Individuals with mutations in the NCF2 gene have a reduced capacity to produce these reactive oxygen species, making them more susceptible to infections. Genetic testing for mutations in the NCF2 gene can confirm a diagnosis of CGD and help in managing and treating the condition more effectively.

In the United Arab Emirates, DNA Labs UAE offers a genetic test for identifying mutations in the NCF2 gene. The test is crucial for families with a history of CGD, as it can help in early diagnosis and intervention for affected individuals. The cost of the test is 4400 AED. Early diagnosis through genetic testing can significantly improve the quality of life for individuals with CGD by enabling tailored treatments and preventive measures against infections.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

NCF2 Gene Granulomatous Disease Chronic Autosomal Recessive Cytochrome b-Positive Type 2 Genetic Test

Welcome to DNA Labs UAE, where we offer the NCF2 Gene Granulomatous Disease Chronic Autosomal Recessive Cytochrome b-Positive Type 2 Genetic Test. This test is designed to diagnose and provide valuable insights into this genetic disorder. Read on to learn more about the test details, components, price, and more.

Test Components

  • Test Name: NCF2 Gene Granulomatous Disease Chronic Autosomal Recessive Cytochrome b-Positive Type 2 Genetic Test
  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Hematology
  • Doctor: Hematologist
  • Test Department: Genetics

Pre Test Information

Before undergoing the NCF2 Gene Granulomatous Disease Chronic Autosomal Recessive Cytochrome b-Positive Type 2 Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by the NCF2 Gene Granulomatous Disease Chronic Autosomal Recessive Cytochrome b-Positive Type 2 NGS Genetic DNA Test gene NCF2.

Test Details

The NCF2 gene is associated with a condition called granulomatous disease, chronic, autosomal recessive. This genetic disorder affects the immune system, leading to recurrent infections and the formation of granulomas (inflammatory nodules) in various organs. The term “cytochrome b-positive” refers to a specific type of granulomatous disease caused by mutations in the NCF2 gene. This type is characterized by abnormal function of the cytochrome b component of the NADPH oxidase enzyme complex, which is involved in the production of reactive oxygen species (ROS) by immune cells. Defects in this enzyme complex impair the ability of immune cells to kill certain bacteria and fungi, leading to recurrent infections and the formation of granulomas.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the context of NCF2 gene granulomatous disease, an NGS genetic test can be used to identify mutations or variants in the NCF2 gene that may be responsible for the condition. This test can help confirm a diagnosis, determine the specific genetic cause, and guide appropriate management and treatment options for affected individuals and their families.

Test Name NCF2 Gene Granulomatous disease chronic autosomal recessive cytochrome b-positive type 2 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Hematology
Doctor Hematologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for NCF2 Gene Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with NCF2 Gene Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2 NGS Genetic DNA Test gene NCF2
Test Details

The NCF2 gene is associated with a condition called granulomatous disease, chronic, autosomal recessive. This genetic disorder affects the immune system, leading to recurrent infections and the formation of granulomas (inflammatory nodules) in various organs.

The term “cytochrome b-positive” refers to a specific type of granulomatous disease caused by mutations in the NCF2 gene. This type is characterized by abnormal function of the cytochrome b component of the NADPH oxidase enzyme complex, which is involved in the production of reactive oxygen species (ROS) by immune cells. Defects in this enzyme complex impair the ability of immune cells to kill certain bacteria and fungi, leading to recurrent infections and the formation of granulomas.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the context of NCF2 gene granulomatous disease, an NGS genetic test can be used to identify mutations or variants in the NCF2 gene that may be responsible for the condition. This test can help confirm a diagnosis, determine the specific genetic cause, and guide appropriate management and treatment options for affected individuals and their families.

SKU: TEST-3904 Category:

Related products